I note Neu is expecting payments of $120 million for FY 22/23 on potential approval of Trof in March and is sitting at $6.50 at close. It’s marketing partner Acadia is taking on manufacturing, distribution etc… these are milestone payments coming to NEU.
Botanix if SB accepted and company manufactures themselves will have set up/ marketing / distribution costs etc. 12 months time frame for decision. Euroz Hartley in recent report (comparing to Qbrexa) suggests if BOT is able to capture just 1% of AH market that will be Revenue of $143 US million alone.
Just on AH success alone and high likelihood of approval - yes this stock is being missed by the market.
Pending announcements Q3 and Q4, page-63
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.5¢ | 37.5¢ | $4.475M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37310 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 54981 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |